Proprio
Proprio is a technology company modernizing surgery by combining physician expertise with immersive, intelligent technology. Their proprietary platform utilizes light field technology, computer vision, data intelligence, and real-time anatomical alignment to provide surgeons with insightful, responsive information in the operating room. This aims to increase screw accuracy, decrease complications and readmission rates, reduce revisions, lower radiation exposure, and decrease OR time and hospital stay. The company is founded by a team of experienced technologists, creatives, and trailblazers, including CEO and Co-Founder Gabe Jones and CMO and Co-Founder Dr. Sam Browd.
Proprio
Proprio is a technology company modernizing surgery by combining physician expertise with immersive, intelligent technology. Their proprietary platform utilizes light field technology, computer vision, data intelligence, and real-time anatomical alignment to provide surgeons with insightful, responsive information in the operating room. This aims to increase screw accuracy, decrease complications and readmission rates, reduce revisions, lower radiation exposure, and decrease OR time and hospital stay. The company is founded by a team of experienced technologists, creatives, and trailblazers, including CEO and Co-Founder Gabe Jones and CMO and Co-Founder Dr. Sam Browd.
TL;DR
Product: Paradigm — AI-driven, light-field imaging platform for real-time 3D surgical guidance (initial focus: spine)
Founded / HQ: Founded 2016; headquartered in Seattle
Funding: Raised Series A (~$23M) and Series B ($43M); total funding reported ~$85.1M
Founders: Co‑founders include Gabe (Gabriel) Jones, Dr. Samuel (Sam) Browd, Joshua Smith, and James Youngquist
Company Overview
Problem Domain
Intraoperative surgical visualization, navigation, and measurement for spine surgery (reducing complications, revisions, radiation, and OR time).
Founded
2016
Industry
Surgical technology / medical devices
Tech Stack
Funding Track Record
23000000.00
Series A announced June 17, 2020
43000000.00
Series B announced July 27, 2023
Investor Signal
“DCVC, BOLD Capital Partners, Cota Capital, Intel, HTC and other institutional and strategic backers listed as investors/partners”